Clinical Trial Update: A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

View source ↗

Summary

AbbVie-sponsored trial evaluating hair changes in adults taking Oriahnn for heavy menstrual bleeding due to uterine fibroids has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• ORIAHNN (ELAGOLIX AND ESTRADIOL AND NORETHISTERONE)

Snippet

Sponsor: AbbVie | Conditions: Uterine Fibroids (UF) | Status: WITHDRAWN